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Traumatic brain injuryAutophagy is a homeostatic, carefully regulated, and dynamic process for intracellular recycling of bulk
proteins, aging organelles, and lipids. Autophagy occurs in all tissues and cell types, including the brain and
neurons. Alteration in the dynamics of autophagy has been observed in many diseases of the central nervous
system. Disruption of autophagy for an extended period of time results in accumulation of unwanted
proteins and neurodegeneration. However, the role of enhanced autophagy after acute brain injury remains
undeﬁned. Established mouse models of brain injury will be valuable in clarifying the role of autophagy after
brain injury and are the topic of discussion in this review.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Autophagy is a homeostatic, carefully regulated, and dynamic
process for intracellular recycling of bulk proteins and aging
organelles [1,2] and very recently discovered lipids [3]. Alteration in
the dynamics of autophagy has been observed in many diseases of the
central nervous system (CNS). Increased autophagy has now been
reported in experimental models of traumatic brain injury, stroke, and
excitotoxicity [4–7] and in patients with Alzheimer's disease and
critical illness [8,9]. Mice with genetic disruption of autophagy
develop accumulation of unwanted proteins and neurodegeneration,
mimicking human conditions like Huntington's, Parkinson's, and
Alzheimer's disease [10]. However, while lifetime disruption of
autophagy is clearly deleterious, it remains unclear whether increased
autophagy after critical injury or extended periods of cell stress is
beneﬁcial—or actually detrimental. Several studies using transgenic
mice and/or established mouse models of brain injury have shed
some light onto the role of autophagy after brain injury. However, the
role of autophagy, particularly in the brain, remains controversial and
is the topic of this review.n Research, 3434 Fifth Avenue
+1 412 692 6076.
.
ll rights reserved.2. Autophagy
Autophagy occurs in all tissues and cell types, including the brain
and neurons. Autophagy is an important cellular response to
environmental stress. The classic stimulus for autophagy is starvation.
Starvation-induced autophagy is initiated by extended nutrient
deprivation, the hormone glucagon, and the second-messenger
cAMP [11,12]. Autophagy is a highly regulated process requiring the
ubiquitin E1-like enzyme Atg7 (autophagy-associated proteins ab-
breviated “Atg”), phosphorylation of pre-autophagosomal mem-
branes, formation of Atg12-Atg5 complexes, and processing of
Atg8/microtubule-associated protein light chain-3 (LC3, is the
mammalian homologue of the yeast Atg8), and covalent attachment
of phosphatidyl-ethanolamine to LC3-I resulting in LC3-II (Fig. 1).
LC3-II is a relatively speciﬁc biochemical footprint of autophagy,
referred to as an “LC3 shift” or “LC3 lipidation” [13]. These processes
culminate in the formation of autophagosomes containing cytoplas-
mic material and/or organelles such as mitochondria. Autophago-
somes fuse with lysosomes, facilitating enzymatic disassembly of
large proteins and organelles leading to recycling of amino acids
and other nutrients [14]. Starvation-induced autophagy is regulated
by class III phosphatidylinositol 3-kinase (PI3-K) and the Bcl-2
interacting partner, Beclin-1 [15]. In contrast, regulation of autophagy
may differ in non-starvation conditions. For example, the mitogen
activated protein kinase/extracellular signal regulated protein
kinases (MEK), rather than PI3-K, appear to regulate autophagy
Fig. 1. (A) Simpliﬁed schematic of starvation- and non-starvation-induced autophagy. Putative effectors of autophagy are highlighted in white boxes. (B) Electron micrograph
showing autophagosomes (the “gold standard” for detection of autophagy) in an axons after traumatic brain injury in mice (bar=100 nm). Abbreviations: 3-MA, 3-methyladenine;
Atg, autophagy complex component; ERK, extracellular signal regulated protein kinase; GAIP, Gα-interacting protein; GCEE, γ-glutamyl cysteine-ethyl ester; LC3, light chain 3; MEK,
mitogen activated protein kinase/ERK; mTOR, mammalian target of rapamycin; P, phosphate; PE, phosphatidylethanolamine; PI3-K, phosphoinositide 3-kinase; PKB, protein kinase
B; U0126, 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene.
919A.K. Au et al. / Biochimica et Biophysica Acta 1802 (2010) 918–923triggered by oxidative stress as the MEK inhibitor 1,4-diamino-2,3-
dicyano-1,4-bis[2-aminophenylthio]butadiene (U0126), but not the
class III PI-3K inhibitor 3-methyladenine, reduces autophagy induced
by 1-methyl-4-phenylpyridinium [16]. Importantly, oxygen radicals
are also essential for autophagy to proceed normally [17].
3. Mouse model to monitor autophagy
As brieﬂy noted above, LC3-II is a reliable biomarker of autophagy.
Taking advantage of this, Mizushima et al. developed a transgenic
mouse where LC3 is tagged with green ﬂuorescent protein (GFP) [18].
GFP-LC3 is concentrated in autophagosomes, and thus formation of
GFP-enriched vesicles can be used to monitor autophagy [1].
Hemizygous expression of GFP-LC3 does not itself affect autophagy
rates, and GFP-LC3 localizes to autophagosome membranes upon
stimulation of autophagy similar to endogenous LC3 [19]. GFP
ﬂuorescent macroscopy can be used to identify transgenic embryos
(Fig. 2A). GFP-LC3+/- transgenic mice can be used to monitor
autophagy both in vivo and in vitro. Mizushima et al. evaluated GFP-
LC3+/- mice and found that the response to nutrient deprivation was
tissue-speciﬁc [18]. In some tissues, such as the brain, ovaries, and
testes, an increase in autophagy after 48 h of starvation was not
detectable. In others, such as the kidney, pancreas, and thymus,
baseline autophagy was observed in some cell types. In most tissues,
particularly the liver and muscle, 48 h of nutrient deprivation
produced a reliable and robust increase in autophagosome formation.
The value of thesemice in the dynamic assessment of autophagy in
neurons was ﬁrst demonstrated in an in vitro model of starvation.
Depriving neurons of D-glucose, sodium pyruvate, L-glutamate, L-glu-
tamine, L-aspartate, and supplements containing protein and lipid,
leads to formation of GFP-LC3 enriched vacuoles (consistent with
autophagosomes) within an hour (Fig. 2) [20]. Cultures from these
mice can be used to track fusion of autophagosomes with lysosomes
[20] andmitochondria (Fig. 2C). In contrast to ﬁbroblasts, inhibition of
autophagy using 3-methyladenine—a classic but non-speciﬁc inhib-
itor of autophagy, or siRNA targeting Atg7, increased neuronal
survival, suggesting that in non-dividing cells such as neurons,
increased autophagy is deleterious. Another interesting ﬁnding in
this studywas that during starvation, induction of autophagywas sex-
dependent [20]. Neurons from male mice show a robust increase inautophagosomes versus their female counterparts during starvation.
Both resistance to starvation and decreased autophagy in neuronswas
associated with the capacity of neurons from females to mobilize lipid
sources and form lipid droplets. Very recently, a critical link between
LC3 lipidation and autophagy of lipid droplets was reported, a process
coined “lipophagy” [3].
Because 48 h of food deprivation does not produce detectable
autophagy in brains from mice [18], the in vivo relevance of this in
vitro starvation model, can be questioned. However, studies in
humans with prolonged periods of profound starvation—those
undergoing voluntary hunger strikes and patients with anorexia
nervosa, show radiographic evidence of brain tissue loss, consistent
with some degree of autophagy and/or lipophagy in brain [21–23].
Since it would be difﬁcult to justify subjecting animals to extended
periods of starvation, this question may never be answered.
Nevertheless, what is clear is that neurons retain the capacity to
undergo autophagy, the role of autophagy in response to stress may
be different in neurons compared to other tissues—particularly those
that also serve as nutrient depots such as adipose, liver, and skeletal
muscle, and that the autophagic response to stress is sex-dependent.
4. Mouse models of disrupted autophagy
4.1. Atg7 deﬁcient transgenic mice
In 2005, Komatsu et al. reported generation of conditional
knockoutmice deﬁcient in Atg7 [24]. They found that mice completely
lacking Atg7 die within 1 day after birth. The following year, this
group reported generation of mice with tissue-speciﬁc Atg7 knock-
down in the CNS [10]. These mice had growth retardation, motor and
behavioral deﬁcits, and extensive neuronal loss, dying within 28
weeks of birth. Additionally, age-dependent increases in ubiquitin-
containing inclusion bodies were present in neurons reﬂecting
disrupted autophagy and correlating with neurodegeneration and
neurological dysfunction.
Koike et al. evaluated the inﬂuence of CNS Atg7 deﬁciency in a
mouse model of neonatal hypoxia–ischemia [25]. This adaptation of
the Levine preparation [26] is often referred to as the Rice–Vannucci
model when used in immature rodents [27] and involves unilateral
carotid artery ligation followed by a period of hypoxia. This insult can
Fig. 2. Dynamic tracking of autophagy in primary cortical neurons in vitro. (A) Discrimination of GFP-LC3+/- mice using ﬂuorescent macroscopy. (B) Identiﬁcation of GFP-LC3-
enriched vesicles suggestive of autophagosomes in primary cortical neurons from GFP-LC3+/- mice after 24 h of nutrient deprivation using ﬂuorescent microscopy. (C) Dynamic
tracking of mitophagy in primary cortical neurons from GFP-LC3+/- mice using time-lapsed microscopy. Autophagosomes (green) fusing with mitochondria (red; MitoTracker Red,
Invitrogen, Carlsbad, CA) are highlighted by arrows. Time stamp is h:min.
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unilateral brain infarction. Neonatal Atg7 deﬁcient mice had less
hippocampal neuronal death and autophagy compared with their
wild-type counterparts, implying that autophagy contributes to
neurodegeneration after acute cerebral ischemia. Importantly, the
protective effect of Atg7 deletion is not seen in older mice, suggesting
that any advantage Atg7 mice may have in response to ischemia is
counterbalanced by accumulation of proteins with increasing age
related to disrupted autophagy.
4.2. Atg5 deﬁcient transgenic mice
In 2004, Kuma et al. reported generation of homozygous mice
deﬁcient in Atg5-/- [28]. These mice appeared normal at birth, yet
most died within 1 day of life. Atg5 and Atg12-Atg5 conjugates were
undetectable in these mice. LC3-II was signiﬁcantly reduced or absent,
and LC3-I was increased. In neural-cell-speciﬁc Atg5-/- mice, devel-
opment of progressivemotor and behavioral deﬁcits and degenerative
changes in neurons is observed, again illustrating the necessity of
autophagy in cellular homeostasis.
5. Mouse models of enhanced autophagy
Both transgenic and non-transgenic mousemodels have been used
to provide valuable insight into the pathobiology and pathophysiol-
ogy of acute brain injury [29]. Recently, contemporary mouse models
of traumatic and ischemic brain injury have shown increased
autophagy and have begun to shed some light—or perhaps a cloud
of controversy, as to the role of autophagy in the mature and
developing mammalian brain. Speciﬁcally, whether autophagy is
beneﬁcial and/or detrimental, or merely an epiphenomenon after
acute brain injury.
5.1. Traumatic brain injury
The ﬁrst report that traumatic brain injury may stimulate
autophagy was by Diskin et al. in 2005 [30]. Using a mouse model
of closed head injury produced by dropping a weight onto the intact
skull, they assessed changes in Beclin-1, a bcl-2 interacting partner
that regulates starvation-induced autophagy. They found that whileBeclin-1 levels are relatively low in brain from uninjured animals,
Beclin-1 increased in neurons and activated astrocytes at the site of
injury [30]. Thus, providing indirect evidence that autophagy is
increased after traumatic brain injury. Investigators from this
laboratory later evaluated the effects of treatment with rapamycin
in this closed head injury model [31]. Rapamycin triggers autophagy
via inhibition of mammalian target of rapamycin (mTOR) and
consequential disinhibition and activation of PI3-K (Fig. 1A). Rapa-
mycin was developed as an anti-fungal agent and also has anti-
inﬂammatory effects and the ability to cause cell cycle arrest and
inhibit cell proliferation [32]. Erlich et al. [31] found that intraperi-
toneal injection of rapamycin administered 4 h after injury resulted in
improved neurobehavioral function as determined by a neurological
severity score and increased neuronal survival in the injured region
compared to vehicle treated mice. Additionally, Western blot showed
increased Beclin-1 at 5 h in with rapamycin treatment, consistent
with an augmented autophagic response. Collectively, these data
support rapamycin-enhanced autophagy producing beneﬁcial neuro-
logical effects after traumatic brain injury. Although, non-autophagic
salutatory effects of rapamycin cannot be discounted.
Ultrastructural identiﬁcation of autophagosomes remains the
“gold standard” method for detection of autophagy [1]. As such, the
ﬁrst direct evidence that autophagy is increased after traumatic brain
injury was reported by Lai et al. using a controlled cortical impact
model of traumatic brain injury [4]. Controlled cortical impact is a
contemporary model of traumatic brain injury that produces a
contusion with cortical necrosis, delayed neuronal death in brain
regions such as the hippocampus and thalamus, and sustained motor
and cognitive deﬁcits [33]. An increase in autophagosomes—vacuoles,
multilamellar bodies, and secondary lysosomes, was observed from 2
to 48 h after traumatic brain injury. Biochemical evidence of
autophagy increased LC3-II levels in injured brain was also reported.
As oxidative stress can induce autophagy [17] and oxygen radicals are
essential for autophagy to proceed normally [16], the effect of the
cysteine-donor antioxidant γ-glutamylcysteinyl ethyl ester (GCEE)
was evaluated. Systemic administration of GCEE after injury resulted
in reduced autophagy as determined by LC3-II formation, increased
antioxidant reserves, improved cognitive performance, and reduced
histological damage compared with vehicle treatment. The same
caveat mentioned above regarding non-autophagy related effects of
Fig. 3. Hypothetical schematic illustrating potential dual-roles of autophagy after
critical brain injury.
921A.K. Au et al. / Biochimica et Biophysica Acta 1802 (2010) 918–923rapamycin also applies to GCEE. However, there does appear to be a
link between autophagy and oxidative stress after traumatic brain
injury. Oxidative stress is a prominent feature of traumatic brain
injury in mice [34] and humans [35].
5.2. Hypoxia–ischemia
Similar to traumatic brain injury, autophagy was also reported to
be upregulated after hypoxic–ischemic injury in mice in 2005. Zhu et
al. examined the effects of age and hypoxia–ischemia induced by
unilateral carotid artery occlusion and hypoxemia (Rice–Vannucci
model) on LC3-II levels as a biomarker of autophagy [6]. They detected
levels of LC3-I and LC3-II in control brains, and found that younger
(post-natal day 5; PND 5) animals had higher levels of both LC3-I and
LC3-II compared with older animals (PND 60). Thus, similar to
apoptosis, autophagy appears to be age-dependent and more
prominent during early stages of development. After unilateral
hypoxia–ischemia, relative LC3-II abundance was increased in the
ipsilateral hemisphere, with the greatest increase in adult brains [6].
The following year, this group also reported that this increase in LC3-II
was not sex-dependent in this model of neonatal hypoxia–ischemia
[36].
Autophagic neurodegeneration is also seen after cerebral ischemia
in adult mice. After transient middle cerebral artery occlusion,
Degterev et al. showed an increase in autophagy that was not affected
by the novel “necroptosis” inhibitor Necrostatin-1 [5]. Adhami et al.
reported the effect of unilateral carotid occlusion with hypoxemia in
adult mice [37]. They noted the presence of vacuole-associated
damage via electron microscopy consistent with autophagy in the
ischemic brain. Using GFP-LC3 transgenic mice, they also showed
increased punctate GFP immunolabeling at 6 and 18 h after hypoxia–
ischemia. An increase in LC3-II was not detected after hypoxia–
ischemia; however, a transient reduction in LC3-I and depletion of
cytosolic LC3 was observed.
6. Reconciliation of current studies
To date, mouse models have been valuable in establishing that
autophagy is a vital homeostatic process, and that disrupted
autophagy in normal tissues—including in the brain, is detrimental
[10,28]. Contemporary mouse models have also established that the
autophagic response can be triggered in brain by trauma [4], ischemia
[5,6], and excitotoxicity [7]. However, the role of autophagy—
beneﬁcial, detrimental, or an epiphenomenon, after acute brain injury
remains uncertain and controversial [38,39].
6.1. If not enough autophagy is bad, is more autophagy better?
Undoubtedly autophagy is essential for the clearance and recycling
of accumulated proteins and aging or dysfunctional organelles.
Disruption of autophagy, especially for the lifetime of an animal
leads to accumulation of proteins. If accumulation of the particular
protein or the protein itself happens to be toxic, then functional
autophagy is of greater importance to cellular homeostasis. Examples
of toxic protein accumulation associated with CNS pathology include
mutated Tau, β-amyloid,α-synuclein, and Huntington protein [40]. As
mentioned above, mice with disrupted autophagy due to deletion of
Atg5 or Atg7 demonstrate neuropathology with accumulated protein
aggregates and phenotypic changes mimicking human neurodegen-
erative disease [10,28]. Extrapolating to diseases where increased
autophagy is evident, perhaps this increase is designed to clear
protein aggregates? For example, β-amyloid, sufﬁcient to induce
neuronal apoptosis [41], is known to accumulate after traumatic brain
injury [42].
On the other hand, since baseline autophagy in neurons is low
(indeed rarely detected) and protein synthesis in general is inhibitedafter acute brain injury, increased autophagymay not be necessary for
clearance of protein. In non-human primates after global brain
ischemia, protein synthesis in all brain regions is inhibited within
hours after ischemia [43]. In some regions, such as the cerebellum and
cortex, protein synthesis recovered within 24 h. In others, such as the
hippocampus, thalamus, and arterial border zones of the cortex,
protein synthesis was inhibited by as much as 50% compared with
normal controls. Additionally, chaperone proteins are not subject to
this general reduction in protein synthesis after ischemia [44]. Signals
for autophagic degradation of proteins also include sequence speciﬁc
regions (KFERQ) that interact with chaperone proteins [45]. Chaper-
one-assisted degradation of accumulated proteins versus autophago-
some-lysosomemediated degradation of organelles and bulk proteins
may play different roles after acute brain injury.
Another unanswered question is whether increased autophagy
participates in the clearance of reversibly or irreversibly damaged
organelles or whether its consumption of organelles such as
mitochondria in cells with low baseline autophagy is indiscriminate?
Mitochondrial ﬁssion, which likely occurs before engulfment into
autophagosomes (Fig. 3), is not necessarily irreversible after injury
[46]. Enhanced autophagy may contribute to consumption of
potentially viable or uninjured organelles such as mitochondria
after ﬁssion, and therefore, may exacerbate energy failure and worsen
injury. Mitochondrial dysfunction [47,48] and energy failure [49] are
prominent features of both traumatic and ischemic brain injury.
Addressing this question directly has been hampered by the fact
that studies in autophagy-related transgenic mice are confounded
by progressive neurodegeneration as the mouse ages, and the lack
of speciﬁc pharmacological agents targeting autophagy. In the study
by Koike et al. using Atg7 deﬁcient mice, cerebral ischemia was
imposed on PND 7, and brains were evaluated 3 days later [25],
long before neuropathology is detectable in these mice [10]. The
studies by Erlich et al. [31] and Lai et al. [4] testing pharmacological
therapies that increase and inhibit autophagy, respectively, in
mouse models of traumatic brain injury were conﬂicting. Rapamy-
cin, which induces autophagy via inhibition of mTOR improved
neurological outcome [31], whereas the antioxidant GCEE reduced
autophagy but also improved neurological outcome [4]. As noted
above, both of these studies tested drugs with multiple effects in
addition to those related speciﬁcally to autophagy. A more recent
study in a rat model of transient focal cerebral ischemia in PND 12
rats [50] tested what was regarded as a more selective inhibitor of
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treatment with 3-methyladenine administered intracerebroventri-
cularly reduced infarction size compared with vehicle treatment and
caspase inhibitors, which had no effect [50]. Similar to rapamycin
and GCEE, however, 3-methyladenine also has other effects
including inhibition of non-class III PI3-kinases and promotion of
glycogen breakdown in hepatocytes [51]. Taken together, these
pharmacological studies tend to cloud, rather than clarify, the role
of autophagy after acute brain injury.
6.2. Is the role for autophagy cell-type dependent?
Another important question is whether the role of autophagy in
neurons and/or brain is different from other cell types and tissues?
Autophagy at baseline and during starvation is clearly tissue-
dependent [18]. It is interesting to note that tissues that also serve
as nutrient depots, protein in muscle and glycogen in liver, tend to
have robust autophagic responses that are probably beneﬁcial to the
organism as a whole. While curiously evidence for GFP-enriched
vesicles were not routinely observed in fat [18], recent evidence
suggests that regulation of lipid during starvation may be via an
autophagic process [3]. In contrast, typically non-dividing cells such as
neurons, spermatocytes, and oocytes have minimally detectable
autophagy at baseline and do not have an autophagic response to
48 h of starvation [18]. Inhibition of autophagy during nutrient
deprivation reduces cell death in neurons but increases cell death in
ﬁbroblasts [20], suggesting that not only is the autophagic response
tissue-dependent, but the role of autophagy is as well.
7. Conclusions
While mouse models have helped establish the presence of
autophagy in brain after acute injury, they have not yet helped clarify
the role of autophagy. However, it seems clear that either too little, or
too much, autophagy is detrimental to normal homeostasis and the
response to injury and that this is tissue- and cell-type-dependent. In
this regard, autophagy is quite like apoptosis. Indeed, many other
similarities and cross-talk occur between autophagy and apoptosis
[52]. Important unanswered questions remain that will require
development and testing of speciﬁc interventions that either increase
or inhibit autophagy in injured brain, before these questions can be
answered.
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